US Broker Ratings

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 10.49% Potential Upside

For investors seeking exposure to the dynamic biopharmaceutical space, Royalty Pharma plc (NASDAQ: RPRX) presents a compelling proposition. Specializing in the acquisition of biopharmaceutical royalties, Royalty..

The Cooper Companies, Inc. (COO)

⚠️ No article content returned.

..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 33.87% Potential Upside in the Healthcare Sector

Waystar Holding Corp. (NASDAQ: WAY), a rising star in the healthcare sector, is capturing the attention of investors with its robust potential upside of 33.87%, according..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Solid Healthcare Play with a 17.46% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN) has captured the attention of investors with its promising position in the healthcare sector, particularly in the Medical Instruments & Supplies..

Danaher Corporation (DHR) Stock Analysis: Healthcare Powerhouse with 12.60% Potential Upside

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, is drawing the attention of discerning investors with its robust market presence and promising growth..

Align Technology, Inc. (ALGN) Stock Analysis: Unveiling a 15% Potential Upside in the Dynamic Medical Instruments Sector

Align Technology, Inc. (NASDAQ: ALGN), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling case for investors..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unraveling the 87.70% Potential Upside

Investors eyeing the biotechnology sector should take a closer look at Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company with an ambitious pipeline of vaccine..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring the 12.18% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans sector, is capturing the attention of investors with its promising potential upside of 12.18%...

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.38% Potential Upside Amidst Health Information Services Growth

Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services sector, is catching the eye of investors with its digital platform tailored for medical..

Bio-Techne Corp (TECH) Stock Analysis: Navigating the Biotech Giant’s Modest Growth and Analyst Consensus

Bio-Techne Corp (NASDAQ: TECH) stands as a prominent player in the biotechnology sector, with a market capitalization of $11.28 billion. Based in Minneapolis, Minnesota, the company..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 6.21% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a significant player in the healthcare sector, specifically within the realm of specialty and generic drug manufacturing. With a..

Alkermes plc (ALKS) Stock Analysis: A Look at the 14.15% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is making waves in the biopharmaceutical industry with a robust portfolio that addresses unmet medical..

argenx SE (ARGX) Stock Analysis: Biotech Giant with a 29% Upside Potential

Investors seeking opportunities in the biotechnology sector should pay close attention to argenx SE (NASDAQ: ARGX), a leading biopharmaceutical company based in the Netherlands. Specializing in..

Ionis Pharmaceuticals (IONS) Stock Analysis: Exploring a 56% Potential Upside in Biotech Innovation

For investors with an eye on the healthcare sector, Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents a compelling case for consideration. Known for its pioneering work in..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Significant 33.58% Upside Potential with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to addressing central nervous system..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the biotechnology sector, offering investors a compelling opportunity amid its dynamic growth trajectory and strategic partnerships. With a..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: 38.54% Potential Upside Beckons Investors

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is capturing investor attention with its promising financial trajectory and robust pipeline of pharmaceutical developments. As a key player in the..

HealthEquity, Inc. (HQY) Stock Analysis: A Look at Strong Buy Ratings and 13% Upside Potential

HealthEquity, Inc. (HQY) stands out in the healthcare sector with its strategic focus on providing technology-enabled services platforms tailored for consumers and employers. With a market..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Promising 10.48% Upside for Investors

Merit Medical Systems, Inc. (MMSI), a prominent player in the medical instruments and supplies industry, offers a compelling investment opportunity in the healthcare sector. With a..

BridgeBio Pharma (BBIO) Stock Analysis: A Biotech Pioneer with a 35.77% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a key player in the biotechnology sector, specializing in the development of novel therapies for genetic diseases. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds